Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/ml400027y http://scihub22266oqcxt.onion/10.1021/ml400027y C4027226!4027226 !24900686     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24900686 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       ACS+Med+Chem+Lett 2013 ; 4 (4 ): 414-8 Nephropedia Template TP {{tp|p=24900686 |t=2013. Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes |pdf=|usr=}}{{24900686 }} gab.com Text Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes JO: ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=24900686 #FOAvip To resolve the metabolite redox cycling associated with our earlier clinical compound 2, we carried out lead optimization of lead molecule 1. Compound 4 showed improved lipophilic ligand efficiency and demonstrated robust glucose lowering in diet-induced obese mice without a liability in predictive preclinical drug safety studies. Thus, it was selected as a clinical candidate and further studied in type 2 diabetic patients. Clinical data suggests no evidence of metabolite cycling, which is consistent with the preclinical profiling of metabolism. Twit Text FOAVip Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes ????ACS Med Chem Lett http://www.kidney.de/pget.php?&tw=1&pmid=24900686 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24900686 #FOAvip English Wikipedia <ref>{{Cite pmid|24900686 }}</ref> Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes #MMPMID24900686 Qian Y ; Corbett WL ; Berthel SJ ; Choi DS ; Dvorozniak MT ; Geng W ; Gillespie P ; Guertin KR ; Haynes NE ; Kester RF ; Mennona FA ; Moore D ; Racha J ; Radinov R ; Sarabu R ; Scott NR ; Grimsby J ; Mallalieu NL ACS Med Chem Lett 2013[Apr]; 4 (4 ): 414-8 PMID24900686 show ga To resolve the metabolite redox cycling associated with our earlier clinical compound 2, we carried out lead optimization of lead molecule 1. Compound 4 showed improved lipophilic ligand efficiency and demonstrated robust glucose lowering in diet-induced obese mice without a liability in predictive preclinical drug safety studies. Thus, it was selected as a clinical candidate and further studied in type 2 diabetic patients. Clinical data suggests no evidence of metabolite cycling, which is consistent with the preclinical profiling of metabolism. ?Identification of RO4597014, a Glucokinase Activator Studied in the Cl(epmc).pdf DeepDyve Pubget Overpricing